{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:06:57Z","timestamp":1794330417014,"version":"4.9.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.semarthrit.2025.152782","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:06:17Z","timestamp":1752642377000},"page":"152782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cost-effectiveness of nurse-led home monitoring of serum urate for gout patients starting with urate-lowering therapy in secondary care: a modeling study"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0897-2149","authenticated-orcid":false,"given":"Jeffrey","family":"van der Ven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Flendrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4920-9018","authenticated-orcid":false,"given":"Fenne","family":"van Dijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike H.M.","family":"Wientjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noortje","family":"van Herwaarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3029-7098","authenticated-orcid":false,"given":"Philip L.","family":"Riches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.F.","family":"van den Bemt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise M.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2025.152782_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13696998.2018.1532904","article-title":"The economic burden of uncontrolled gout: how controlling gout reduces cost","volume":"22","author":"Flores","year":"2019","journal-title":"J Med Econ"},{"issue":"10055","key":"10.1016\/j.semarthrit.2025.152782_bib0002","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152782_bib0003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10156","key":"10.1016\/j.semarthrit.2025.152782_bib0004","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2025.152782_bib0005","unstructured":"Eysink P., Poos M., Gijsen R., Kommer G., van Gool C. Epidemiologische data van ziekten van het botspierstelsel en bindweefsel: achtergrondrapport voor programma zinnige zorg. 2019."},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152782_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-009316","article-title":"The global health workforce stock and distribution in 2020 and 2030: a threat to equity and 'universal' health coverage?","volume":"7","author":"Boniol","year":"2022","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.semarthrit.2025.152782_bib0007","doi-asserted-by":"crossref","first-page":"m2521","DOI":"10.1136\/bmj.m2521","article-title":"Self-management interventions to reduce healthcare use and improve quality of life among patients with asthma: systematic review and network meta-analysis","volume":"370","author":"Hodkinson","year":"2020","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152782_bib0008","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/bmjqs-2017-007635","article-title":"Self-management capability in patients with long-term conditions is associated with reduced healthcare utilisation across a whole health economy: cross-sectional analysis of electronic health records","volume":"27","author":"Barker","year":"2018","journal-title":"BMJ Qual Saf"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152782_bib0009","article-title":"The impact of eHealth interventions on the improvement of self-care in chronic patients: an overview of systematic reviews","volume":"12","author":"Renzi","year":"2022","journal-title":"Life (Basel)"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152782_bib0010","doi-asserted-by":"crossref","first-page":"rkae125","DOI":"10.1093\/rap\/rkae125","article-title":"Support needs of gout patients and suitability of eHealth to address these needs","volume":"8","author":"van der Ven","year":"2024","journal-title":"Rheumatol Adv Pract"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152782_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(22)00062-5","article-title":"Evaluation of supported self-management in gout (GoutSMART): a randomised controlled feasibility trial","volume":"4","author":"Riches","year":"2022","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152782_bib0012","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.2196\/mhealth.9811","article-title":"mHealth app patient testing and review of educational materials designed for self-management of gout patients: descriptive qualitative studies","volume":"6","author":"Nguyen","year":"2018","journal-title":"JMIR Mhealth Uhealth"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152782_bib0013","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/bcp.15657","article-title":"Optimizing adherence to allopurinol for gout: patients' perspectives","volume":"89","author":"Spragg","year":"2023","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152782_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/hex.14071","article-title":"The experiences and perspectives of people with gout on urate self-monitoring","volume":"27","author":"Michael","year":"2024","journal-title":"Health Expect"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152782_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/135581969700200107","article-title":"The iterative use of economic evaluation as part of the process of health technology assessment","volume":"2","author":"Sculpher","year":"1997","journal-title":"J Health Serv Res Policy"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152782_bib0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41927-022-00261-3","article-title":"Effect of metformin use on clinical outcomes and serum urate in gout patients with diabetes mellitus: a retrospective cohort study","volume":"6","author":"Veenstra","year":"2022","journal-title":"BMC Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152782_bib0017","article-title":"Sex differences in response to allopurinol and benzbromarone in gout: a retrospective cohort study","volume":"5","author":"Veenstra","year":"2021","journal-title":"Rheumatol Adv Pract"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152782_bib0018","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Mak"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152782_bib0019","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"23","key":"10.1016\/j.semarthrit.2025.152782_bib0020","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152782_bib0021","first-page":"453","article-title":"Cost-effectiveness of febuxostat in chronic gout","volume":"15","author":"Beard","year":"2014","journal-title":"Eur J Health Econ"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152782_bib0022","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1185\/03007990903017966","article-title":"Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis","volume":"25","author":"Halpern","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152782_bib0023","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/13696998.2020.1757456","article-title":"Cost-effectiveness of sequential urate lowering therapies for the management of gout in Singapore","volume":"23","author":"Pruis","year":"2020","journal-title":"J Med Econ"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152782_bib0024","article-title":"Comparative effectiveness of allopurinol and febuxostat in gout management","volume":"1","author":"O'Dell","year":"2022","journal-title":"NEJM Evid"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152782_bib0025","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40273-020-00937-z","article-title":"Estimating transition probabilities from published evidence: a tutorial for decision modelers","volume":"38","author":"Gidwani","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.semarthrit.2025.152782_bib0026","series-title":"Kostenhandleiding voor economische evaluaties in de gezondheidszorg: methodologie en referentieprijzen","author":"Hakkaart-van Roijen","year":"2024"},{"key":"10.1016\/j.semarthrit.2025.152782_bib0027","unstructured":"Salarisschalen, premies & vergoedingen Nederlandse Vereniging van Ziekenhuizen (NVZ). 2024."},{"key":"10.1016\/j.semarthrit.2025.152782_bib0028","unstructured":"Zorgautoriteit Nederland. Tarieventabel dbc-zorgproducten en overige-zorgproducten per 1 januari 2019. 2019."},{"key":"10.1016\/j.semarthrit.2025.152782_bib0030","unstructured":"Kenneth R.P. Febuxostat 80mg and 120mg tablets (Adenuric\u00ae) Scottish Medicines Consortium. 2010."},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152782_bib0031","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1089\/pop.2012.0057","article-title":"Economic burden of gouty arthritis attacks for employees with frequent and infrequent attacks","volume":"16","author":"Lynch","year":"2013","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.semarthrit.2025.152782_bib0032","unstructured":"Centraal Bureau voor de Statistiek (CBS). Meer dan de helft werkt voltijds. 2020."},{"key":"10.1016\/j.semarthrit.2025.152782_bib0033","author":"Nederland","year":"2015","journal-title":"Kosteneffectiviteit in de praktijk"},{"key":"10.1016\/j.semarthrit.2025.152782_bib0034","first-page":"509","volume":"2","author":"Riches","year":"2024"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152782_bib0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jama.2022.11390","article-title":"Association between gout flare and subsequent cardiovascular events among patients with gout","volume":"328","author":"Cipolletta","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152782_bib0036","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/1756-185X.13855","article-title":"A nurse-led, rheumatologist-assisted telemedicine intervention for dose escalation of urate-lowering therapy in gout","volume":"23","author":"Phang","year":"2020","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152782_bib0037","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.semarthrit.2017.09.007","article-title":"Medication adherence among patients with gout: a systematic review and meta-analysis","volume":"47","author":"Scheepers","year":"2018","journal-title":"Semin Arthrit Rheum"},{"key":"10.1016\/j.semarthrit.2025.152782_bib0038","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1478-4491-11-11","article-title":"Health workforce remuneration: comparing wage levels, ranking, and dispersion of 16 occupational groups in 20 countries","volume":"11","author":"Tijdens","year":"2013","journal-title":"Hum Resour Health"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152782_bib0039","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.semarthrit.2015.07.007","article-title":"Factors associated with access to rheumatologists for Medicare patients","volume":"45","author":"Schmajuk","year":"2016","journal-title":"Semin Arthrit Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152782_bib0040","article-title":"Understanding the global measurement of willingness to pay in health","volume":"8","author":"McDougall","year":"2020","journal-title":"J Mark Access Health Policy"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152782_bib0041","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/cer.15.38","article-title":"Systematic overview of cost-effectiveness thresholds in ten countries across four continents","volume":"4","author":"Schwarzer","year":"2015","journal-title":"J Comp Eff Res"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:58:03Z","timestamp":1780120683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225001532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"alternative-id":["S0049017225001532"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152782","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of nurse-led home monitoring of serum urate for gout patients starting with urate-lowering therapy in secondary care: a modeling study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152782"}}